TFFP (tffpharma.com) Bozor qiymatining balans qiymatiga nisbati

TFF Pharmaceuticals Inc. (TFFP) kompaniyasining rasmiy ramzlari

TFF Pharmaceuticals (TFFP) kompaniyasining strategik o'sishi litsenziyalash shartnomalari orqali vaksina ishlab chiquvchilar bilan hamkorlikka tayanadi. Kompaniyaning joriy P/BV koeffitsiyenti ushbu tendentsiyani aks ettiradi, bunda 0.07 joriy ko'rsatkichni shakllantiradi. Daromadlar Big Pharma kompaniyalari tomonidan patentlardan foydalanganlik uchun to'lanadigan royalti to'lovlariga asoslangan, muvaffaqiyat esa kukun shakllarining bio-mavjudligiga va dori vositalarini yetkazib berish shartnomalari soniga bog'liq.

TFFP TFF Pharmaceuticals, Inc: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 21.12.2024 oraligʻida

TFF Pharmaceuticals Inc. (TFFP) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi TFF Pharmaceuticals|TFFP - Prognoz darajalari grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati TFF Pharma|TFFP - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati TFF Pharmaceuticals|TFFP - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati tffpharma.com|TFFP - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati TFF Pharmaceuticals|TFFP - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati TFF Pharma|TFFP - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar TFF Pharma
Kompaniyaning dastlabki tahlili:TFF Pharmaceuticals - TFFP
TFF Pharma original mahsuloti

Ushbu koeffitsient biznesning joriy bozor qiymatini uning balans qiymati bilan solishtirish orqali strategik nazorat premiumini belgilaydi. Metrikaning dinamikasi hisobot davrlari orasidagi fundamental kutuvlarning o'zgarishiga nisbatan investorlarning real vaqtdagi bahosini aks ettiradi. Bozor baholovishining balans qiymatidan og'ishini tahlil qilish orqali aktivlar uchun ortiqcha to'lov miqdorini aniqlash mumkin. TFF Pharmaceuticals (TFFP) uchun yuqori premium yupqa plyonkali muzlatish texnologiyasining salohiyati bilan bog'liq. Indikatorning o'sishi vorikonazol klinik sinovlarining muvaffaqiyati va litsenziyalash shartnomalarining ijrosiga bog'liq bo'ladi.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Haleon plc (HLN)|KVUE (kenvue.com) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati enterabio.com ENTX|Kapitallashuvning sof aktivlarga nisbati MindWalk Holdings Inc. (HYFT)|Bozor kapitallashuvining balans qiymatiga multiplikatori ABVC BioPharma Inc. ABVC|Bozor kapitallashuvining balans qiymatiga nisbati Cumberland Pharma|QNTM - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati FibroGen, Inc. (FGEN)|Sof aktivlarga nisbatan bozor kapitallashuvi telomirpharma.com|RANI - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati SNYR|RLYB - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi lexariabioscience.com (LEXX)|Bozor kapitallashuvining balans qiymatiga nisbati Pulmatrix, Inc.|Balans qiymatiga nisbatan bozor qiymati Pheton Holdings Limited PTHL|Aptorum - Bozor kapitallashuvining balans qiymatiga nisbati|LYRA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Impact BioMedical IBO|TNFA (TNF Pharmaceuticals, Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati YCBD|Kapitallashuvning sof aktivlarga nisbati painreform.com|Bozor kapitallashuvining balans qiymatiga nisbati CYTO|Bozor kapitallashuvining balans qiymatiga nisbati Lipella Pharmaceuticals Inc (LIPO)|Optinose - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Pieris Pharma PIRS|PROC (Procaps Group S.A.) - Bozor kapitallashuvining balans qiymatiga nisbati|petrospharma.com (PTPI) - Bozor qiymatining balans qiymatiga koeffitsiyenti|QLI: Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Acelyrin Inc.